David Rial-Crestelo

5PUBLICATIONS
27CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersGene and molecular therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Jun 27, 2025
Longitudinal Immunoprofiling of the CD8+ T-Cell Response in SARS-CoV-2 mRNA Vaccinees and COVID-19 Patients.

Jesús Emanuel Brunetti, Beatriz Escudero-Pérez, Fátima Lasala

|Nov 30, 2023
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.

Madhusudan Kabra, Tristan J Barber, Clotilde Allavena

|Apr 26, 2023
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.

Inés Suárez-García, Belén Alejos, Victoria Hernando

|Nov 30, 2022
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.

Rosa De Miguel Buckley, David Rial-Crestelo, Rocío Montejano

Pageof 1

Frequent Collaborators

2 joint publications

Rafael Delgado

1 joint publications

Rosa De Miguel Buckley

1 joint publications

Federico Pulido

1 joint publications

Inés Suárez-García